Skip to main content
. 2014 Apr 28;20(16):4526–4535. doi: 10.3748/wjg.v20.i16.4526

Figure 4.

Figure 4

Human epidermal growth factor receptor 2 testing algorithm with fluorescence in situ hybridization reflex testing for both immunohistochemistry 2+ and immunohistochemistry 3+. This testing algorithm was recommended by the United States Food and Drug Administration in relation to approval of trastuzumab for advanced gastric cancer. FISH: Fluorescence in situ hybridization; IHC: Immunohistochemistry.